Title: Life Science Megatrends Shaping Our Future
Abstract: Technology leadership based on a culture of innovation, contribution and sustained R&D investment has been at the core of Agilent’s success through decades of market and technology waves. Today, biology is the field where science and understanding are most rapidly changing. This talk will highlight key megatrends in this ‘century of biology’, and some of the technology contributions underway at Agilent that will underlie tomorrow’s breakthroughs.
Bio: As CTO, Darlene Solomon’s responsibilities include Agilent Research Laboratories which focuses on high impact, longer range research in support of Agilent’s sustained business growth, and Agilent’s programs in university relations, external research, and venture investment. In her leadership role, she works closely with Agilent’s businesses to define the company’s strategy and R&D priorities.
She joined Hewlett-Packard Laboratories as a research scientist and soon moved into leadership as the R&D manager for the Chemical and Biological Systems Department. When Agilent Technologies was spun out from H-P in 1999, she became responsible for R&D/Technology for Agilent’s Life Sciences and Chemical Analysis business. She was promoted to VP and Director, Agilent Laboratories in 2003, and has been Agilent’s CTO and VP since 2006.
Solomon earned her BS in chemistry from Stanford University and a doctorate in bioinorganic chemistry from MIT and completed Stanford’s Executive Development Program. Solomon serves on the board of directors at Materion Corporation and participates in multiple academic and government advisory and review boards. Amongst the recognition for her accomplishments, Solomon was elected to the National Academy of Engineering, elected Fellow of the American Institute for Medical and Biological Engineering, received the USC Viterbi School of Engineering’s Daniel J Epstein Engineering Management Award, and named by Healthcare Technology Report to its Top 25 Women in Biotech.
Seminar Host: Meng Lu